Sunshine Biopharma (SBFMW) Share-based Compensation Growth (1y) (2011 - 2019)
Sunshine Biopharma (SBFMW) Share-based Compensation Growth (1y) (2011 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 26.47% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 47.06% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.60% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 8.33% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | -69.71% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 40.00% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 59.27% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -24.33% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 23.92% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -20.18% |
| Jun 30, 2016 | 125.75% |
| Jun 30, 2015 | -80.37% |
| Dec 31, 2014 | -67.54% |
| Sep 30, 2014 | 181.48% |
| Jun 30, 2014 | 889.00% |
| Mar 31, 2014 | -53.60% |
| Dec 31, 2013 | 8,733.33% |
| Sep 30, 2013 | -70.02% |
| Dec 31, 2012 | -97.65% |
| Dec 31, 2011 | 159.84% |
| Jun 30, 2011 | -99.24% |